Werner Stenzel

Head of Neuromuscular Diagnostic and Research unit/ Professor Dr. med.

Charité - Universitätsmedizin Berlin

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Dr. med. Werner Stenzel is the Head of the Neuromuscular Diagnostic and Research unit at Charité Universitätsmedizin Berlin, Germany. His research primarily focuses on neuromuscular disorders, including anti-synthetase syndrome, myopathology, and inflammatory myopathies. Recent publications include studies on the characteristics of anti-Ha antisynthetase syndrome and the implications of "amyopathic" MDA5-positive dermatomyositis. He is also involved in advancing diagnostic criteria for myositis and has contributed to international workshops aimed at improving clinical trial readiness.

Articles (26)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (16)

Wolfgang Boehmerle

Charite Universitatsmedizin Berlin Klinik für Neurologie mit Experimenteller Neurologie

GERMANY

Werner Stenzel

Research Interests

Explore related searches

Contact this professor

About

Articles (26)

Correspondence to: Clinico‐sero‐pathological characteristics of anti‐Ha antisynthetase syndrome

Valosin-Containing Protein Multisystem Proteinopathy and Myopathology

Demyelinating Sarcoid Polyneuropathy With Reversible Conduction Block: A Case‐Report

3D Electron Microscopic Visualization of Nemaline Rods in a Case of Congenital Myopathy

[Vasculitic involvement of the skeletal muscle and the peripheral nervous system: clinical and neuropathologic perspective].

More than meets the eye

Differentiating idiopathic inflammatory myopathies by automated morphometric analysis of MHC‐1, MHC‐2 and ICAM‐1 in muscle tissue

"Amyopathic" MDA5-positive dermatomyositis with severe lung involvement presenting with net myositic morphological features - insights from an autopsy study.

Anti-Ku + myositis: an acquired inflammatory protein-aggregate myopathy.

Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositis.

Dataset for: Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune-related adverse events.

Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis.

K2P 2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathies.

Meeting report of the 20th International Congress of Neuropathology (ICN) 2023 in Berlin.

Multi-level profiling unravels mitochondrial dysfunction in myotonic dystrophy type 2.

272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16-18 June 2023, Hoofddorp, The Netherlands.

Microglia regulate central nervous system myelin growth and integrity

Analysing cerebrospinal fluid with explainable deep learning: From diagnostics to insights

Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravis.

Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events.

Morphological and molecular comparison of HIV-associated and sporadic inclusion body myositis.

[Neuropathology I: muscular diseases].

[Neuropathology II: diseases of the central and peripheral nervous systems: Outlook on new techniques in electron microscopy].

Assessing and improving the validity of COVID-19 autopsy studies - A multicentre approach to establish essential standards for immunohistochemical and ultrastructural analyses.

A new therapeutic approach with tocilizumab in a 39-year-old patient with recurrent diabetic myonecrosis.

ANO5-related muscle diseases: From clinics and genetics to pathology and research strategies.

Collaborators (16)

Wolfgang Boehmerle

danielle seilhean

Jerome Hendriks

Philipp Seegerer

Sefer Elezkurtaj

Raphael Mohr

Matthias Vorgerd

Hee-yeong Kim

Sebastian Bachmann

Chiseko Ikenaga

Frauke Stascheit

Jenny Meinhardt

David Munro

Robert Biesen

Udo Schneider

Benjamin Englert

Make your next move.